News Tagged ‘Los Angeles

Women on HRT who experience breast tenderness at greater risk of cancer

Breast Cancer Awareness RibbonWomen who reported new-onset breast tenderness following use of estrogen-plus-progestin hormone replacement therapy () were at a much greater risk of developing than women on the same who did not report tenderness in their breasts, according to a study by researchers from the David Geffen School of Medicine at the University of California – Los Angeles.

Read the rest of this entry »

Prempro increases risk of dying from small cell lung cancer

Women who took Wyeth’s hormone replacement therapy () Prempro at least five years are at greater risk of dying from non-small cell lung cancer, according to a recent study presented at an American Society of Clinical Oncology meeting.

Read the rest of this entry »

Drop in breast cancer rates linked to reduction of HRT use

A new study published this week in the New England Journal of Medicine suggests a sudden decrease in in several countries worldwide is likely linked to the 2002 Women’s Health Initiative () finding that hormone replacement therapy (HRT) after menopause can dramatically increase a woman’s risk of and other serious health problems, the Wall Street Journal reports.

Read the rest of this entry »

Strong bones in menopause may increase risk of breast cancer

Strong bones may make older, post-menopausal women at greater risk for , according to a study conducted by University of Arizona, reported by KABC-TV in Los Angeles.

Bone scans are used to check for osteoporosis, a disease in which bones become fragile and more likely to break. Women are typically four times more likely than men to suffer from osteoporosis. Because there is a direct relationship between the lack of estrogen after menopause and the development of osteoporosis, most doctors advise older women to have bone density tests every year along with a mammogram.

Read the rest of this entry »

High court may bar claims for FDA-approved drugs

The U.S. Supreme Court will hear arguments today in the first of two cases this term that consumer advocates fear could shut courthouse doors to patients injured by FDA-approved drugs or medical devices.

Legal experts say the cases could also affect lawsuits already filed by tens of thousands of Americans challenging the safety of blockbuster drugs such as Celebrex and Prempro and a host of medical devices.

Read the rest of this entry »